BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17965529)

  • 1. Peritoneovenous shunts for palliation of malignant ascites.
    Mamada Y; Yoshida H; Taniai N; Bandou K; Shimizu T; Kakinuma D; Mizuguchi Y; Ishikawa Y; Akimaru K; Tajiri T
    J Nippon Med Sch; 2007 Oct; 74(5):355-8. PubMed ID: 17965529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK; Stubbs RS
    N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneovenous shunts for palliation of the patient with malignant ascites.
    Schumacher DL; Saclarides TJ; Staren ED
    Ann Surg Oncol; 1994 Sep; 1(5):378-81. PubMed ID: 7531600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.
    Tokue H; Takeuchi Y; Arai Y; Sofue K; Sakamoto N; Tsushima Y; Endo K
    World J Surg Oncol; 2011 Jul; 9():82. PubMed ID: 21777451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M; Maetani I; Sakai Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
    Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
    Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunting for nongynecologic malignant ascites.
    Bieligk SC; Calvo BF; Coit DG
    Cancer; 2001 Apr; 91(7):1247-55. PubMed ID: 11283923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliation of malignant ascites by the Denver peritoneovenous shunt.
    Downing R; Black J; Windsor CW
    Ann R Coll Surg Engl; 1984 Sep; 66(5):340-3. PubMed ID: 6207757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of different techniques for the placement of Denver peritoneovenous shunt (PVS) in malignant ascites.
    Clara R; Righi D; Bortolini M; Cornaglia S; Ruffino MA; Zanon C
    Surg Laparosc Endosc Percutan Tech; 2004 Aug; 14(4):222-5. PubMed ID: 15472553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
    Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
    J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneovenous shunt for palliation of malignant ascites.
    Qazi R; Savlov ED
    Cancer; 1982 Feb; 49(3):600-2. PubMed ID: 6174196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
    Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
    Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management.
    Gough IR; Balderson GA
    Cancer; 1993 Apr; 71(7):2377-82. PubMed ID: 7680947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneovenous shunts in malignant ascites.
    Helzberg JH; Greenberger NJ
    Dig Dis Sci; 1985 Nov; 30(11):1104-7. PubMed ID: 2996864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.